Atara Biotherapeutics
ATRA
ATRA
134 hedge funds and large institutions have $776M invested in Atara Biotherapeutics in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 41 reducing their positions, and 26 closing their positions.
Holders
134
Holders Change
-10
Holders Change %
-6.94%
% of All Funds
2.27%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
47
Reduced
41
Closed
26
Calls
$2.32M
Puts
$407K
Net Calls
+$1.92M
Net Calls Change
+$475K
Top Buyers
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$22.9M |
| 2 |
2
Nuveen Asset Management
Chicago,
Illinois
|
$4.06M |
| 3 |
3
Millennium Management
New York
|
$491K |
| 4 |
4
Renaissance Technologies
New York
|
$1.75M |
| 5 |
5
Ameriprise
Minneapolis,
Minnesota
|
$8.42M |
